Concepedia

Lawrence W. Hartley

LW

Statistics

Publications

10

Citations

691

H-Index

10

Active since

1970

Affiliations

Eli Lilly (United States)(Current)

Lawrence W. Hartley is an author at Eli Lilly (United States) specializing in pharmacology, phospholipase a2 inhibition, and enzyme inhibition.

Publications per year

1970–2005

10

Publications

10

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

Richard W. Schevitz, Nicholas J. Bach, D. G. CARLSON et al. · Nature Structural & Molecular Biology · 1995 · 215 citations · Full text

, , +13

Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A<sub>2</sub>. 3. Indole-3-glyoxamides

Susan E. Draheim, Nicholas J. Bach, Robert D. Dillard et al. · Journal of Medicinal Chemistry · 1996 · 91 citations · Full text

, , +10

Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI

David W. Snyder, Nicholas J. Bach, Robert D. Dillard et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 88 citations

, , +15

Transvaginal evisceration after hysterectomy in premenopausal women: A presentation of three cases

Stephen G. Somkuti, Paul A. Vieta, Joseph F. Daugherty et al. · American Journal of Obstetrics and Gynecology · 1994 · 84 citations

, , +14

Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A<sub>2</sub>. 1. Indole-3-acetamides

Robert D. Dillard, Nicholas J. Bach, Susan E. Draheim et al. · Journal of Medicinal Chemistry · 1996 · 70 citations

, , +14

1–5 of 10